US 11193128
Compositions for modulating expression of C9ORF72 antisense transcript
granted A61PA61P21/00A61P25/28
Quick answer
US patent 11193128 (Compositions for modulating expression of C9ORF72 antisense transcript) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61P, A61P21/00, A61P25/28